UTMD

UTAH MEDICAL PRODUCTS, INC.

UTMD · CIK 706698 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$9M
20172024
Net Income$3M
20172024
Operating CF$15M
20172024
Free Cash Flow$15M
20172024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕FY 2017↕
Revenue$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Cost of Revenue$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B—
Gross Profit$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
R&D Expense$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
SG&A Expense————————
Operating Income$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Net Income$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
EPS (Basic)$3.96$4.58$4.53$4.05$2.95$3.96$4.97$2.29
EPS (Diluted)$0.86$1.18$1.25$1.13$0.94$1.17$0.91$2.28

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕FY 2017↕
Total Assets$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B
Current Assets$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B$0.0B
Cash & Equivalents$0.1B$0.1B$0.1B$0.1B$0.1B$0.0B$0.1B$0.0B
Total Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Current Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕FY 2017↕
Operating Cash Flow$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Investing Cash Flow$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$0.0B$-0.0B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
← Companies